Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Enkhe, Badamgarav"'
Publikováno v:
Journal of Clinical Oncology. 37:5548-5548
5548 Background: Limited real-world information is available in ovarian cancer (OC) regarding prognostic factors for disease progression or death after initial treatment. Here, we assessed potential prognostic risk factors in OC patients (pts) who co
Publikováno v:
PharmacoEconomics. 30(2):147-170
Osteoporotic fractures are costly in terms of both the dollar amount and healthcare utilization. The objective of this review was to systematically synthesize published evidence regarding direct costs associated with the treatment of osteoporosis-rel
Publikováno v:
Value in Health. 14(4):571-581
Objectives Therapy for osteoporosis reduces the risk of fracture in clinical trials; real-world adherence to therapy is suboptimal and may reduce the effectiveness of intervention. The objective was to assess the fracture risk among patients nonadher
Autor:
Xue, Song, Nianwen, Shi, Enkhe, Badamgarav, Joel, Kallich, Helen, Varker, Gregory, Lenhart, Jeffrey R, Curtis, Jeffery R, Curtis
Publikováno v:
Bone. 48:828-836
Objectives This retrospective claim-based study assessed 1-year medical costs associated with second fracture(s) for patients over 50 years old with an initial closed hip, clinical vertebral or non-hip non-vertebral (NHNV) fracture using 2002–2008
Publikováno v:
Journal of Bone and Mineral Research. 24:1819-1826
Patients miss doses of their osteoporosis medications, or stop taking them altogether, for a variety of reasons. Whereas the reasons have been well-studied, their consequences, at the population level, have not. The goal of this study was to estimate
Publikováno v:
Mayo Clinic Proceedings. 82:1493-1501
OBJECTIVE To quantify the adherence of patients to drug therapy for osteoporosis in real-world settings via a systematic review and meta-analysis of observational studies. METHODS The PubMed and Cochrane databases were searched for English-language o
Publikováno v:
Mayo Clinic Proceedings. 81:1009-1012
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:4650-4658
The polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of reproductive-aged women today, affecting approximately 6.6% of unselected reproductive-aged women (approximately 4 million women in the United States) (1990 National Ins
Publikováno v:
Supportive Cancer Therapy. 2:34-41
Unlike granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF) is not approved for reducing the incidence or duration of chemotherapy-induced febrile neutropenia. However, some studies have been conduc
Autor:
Chiun-Fang Chiou, Joshua J. Ofman, Enkhe Badamgarav, Joel Wallace, James M. Henning, Loren Laine
Publikováno v:
The American Journal of Gastroenterology. 97:1941-1950
OBJECTIVE: Several strategies exist for the prevention of recurrent ulcer-related hemorrhage, yet the cost-effectiveness has not been evaluated and remains uncertain. The aim of this study was to compare the cost-effectiveness of competing management